Skip to main content
Equibles
ACRV $1.80 +6.51%
ACRV logo
ACRV · Acrivon Therapeutics, Inc.
Track ACRV — free

Use ACRV with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ACRV.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.80 +0.11 (+6.51%)
Rebalance outlook locked
Market Cap
$72.60M
Shares
42.85M
Volume · Oct 20 91.51K Avg daily vol (3M) 316.11K
All webcasts

Earnings call · FY2024 Q4

Acrivon Therapeutics, Inc. (ACRV) Q4 2024 Earnings Call

Concluded Mar 25, 2025
Mar 25, 2025 0 turns
Period
FY2024 Q4
Runtime
—
Sources
3 artifacts
Net income · derived Q4 -$22.83M
Open full screen Slides 48 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. slides, 8-K earnings release, 10-K stay in one workspace.

Research coverage

3 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Presentation 48 slides 8-K earnings release Filed Mar 25, 2025 10-K report Filed Mar 27, 2025 Company webcastOpen the original investor-relations page
Full-screen source Call document

ACRV alerts

Acrivon Therapeutics, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →